Sign in

Revolution Medicines, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 0.00 0.00 0.01 0.04 0.03 0.04 0.05 0.02 0.00
Cost of revenue 0.02 0.59 0.41 0.25 0.19 0.13 0.09 0.05 0.03
Gross profit -0.02 -0.59 0.01 0.04 0.03 0.04 0.05 0.02 -0.03
Total operating expenses + 1.17 0.69 0.50 0.29 0.22 0.15 0.10 0.06 0.00
Operating income -1.18 -0.69 -0.49 -0.26 -0.19 -0.11 -0.05 -0.04 -0.03
Non-operating income (net) 0.05 0.09 0.05 0.01 0.00 0.00 0.00 0.00 0.00
Income before tax -1.13 -0.60 -0.44 -0.25 -0.19 -0.11 -0.05 -0.04 -0.03
Income tax expense 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00
Net income -1.13 -0.60 -0.44 -0.25 -0.19 -0.11 -0.05 -0.04 -0.03
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Total revenue 0.00 0.00 0.00 0.00 0.00 0.26 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Cost of revenue 0.00 0.00 0.00 0.21 0.19 0.15 0.01 0.12 0.14 0.11 0.01 0.07 0.07 0.07 0.06 0.06 0.05 0.05 0.05 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02
Gross profit 0.00 0.00 0.00 -0.21 -0.19 -0.15 -0.01 -0.12 0.00 -0.11 0.00 0.01 0.02 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Total operating expenses + 0.44 0.36 0.32 0.26 0.24 0.22 0.18 0.16 0.14 0.18 0.12 0.11 0.08 0.08 0.08 0.07 0.07 0.06 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.02
Operating income -0.45 -0.36 -0.32 -0.26 -0.24 -0.22 -0.18 -0.16 -0.14 -0.18 -0.12 -0.11 -0.08 -0.06 -0.08 -0.06 -0.06 -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.03
Non-operating income (net) -0.01 0.00 0.01 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.45 -0.36 -0.31 -0.25 -0.21 -0.20 -0.16 -0.13 -0.12 -0.16 -0.11 -0.10 -0.07 -0.06 -0.07 -0.06 -0.06 -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.03
Income tax expense 0.00 -0.16 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.45 -0.36 -0.31 -0.25 -0.21 -0.19 -0.16 -0.13 -0.12 -0.16 -0.11 -0.10 -0.07 -0.06 -0.07 -0.06 -0.06 -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.03
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total cash and short-term investments + 2.03 2.29 1.85 0.64 0.58 0.44 0.12 0.07 0.01
Accounts receivable, net 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Inventories 0.00 0.00 -0.01 0.00 0.01
Other current assets 0.05 0.04 0.03 0.01 0.01 0.01 0.00 0.00 0.00
Total current assets 2.08 2.33 1.88 0.66 0.59 0.45 0.13 0.09 0.01
Total non-current assets + 0.28 0.23 0.18 0.15 0.15 0.11 0.09 0.09 0.01
Total assets 2.35 2.56 2.06 0.81 0.74 0.57 0.22 0.17 0.02
Total current liabilities + 0.29 0.16 0.14 0.06 0.06 0.05 0.04 0.03 0.01
Total non-current liabilities + 0.43 0.13 0.09 0.06 0.08 0.05 0.02 0.04 0.00
Total liabilities 0.72 0.29 0.24 0.13 0.14 0.09 0.07 0.07 0.01
Total stockholders' equity + 1.63 2.27 1.83 0.69 0.60 0.47 0.15 0.10 0.00
Common shares outstanding 190 168 113 81 73 67 36 36 36
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18
Total cash and short-term investments + 1.91 2.03 1.93 2.14 2.10 2.29 1.55 1.59 1.70 1.85 0.81 0.91 0.91 0.64 0.66 0.46 0.52 0.58 0.61 0.65 0.68 0.44 0.47 0.33 0.35 0.12 0.14 0.00 0.07 0.07
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Inventories 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Other current assets 0.06 0.05 0.05 0.04 0.03 0.04 0.03 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01
Total current assets 1.97 2.08 1.98 2.18 2.13 2.33 1.58 1.62 1.73 1.88 0.82 0.92 0.92 0.66 0.68 0.48 0.53 0.59 0.62 0.66 0.70 0.45 0.48 0.34 0.36 0.13 0.15 0.07 0.09
Total non-current assets + 0.29 0.28 0.27 0.25 0.23 0.23 0.18 0.18 0.18 0.18 0.16 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.11 0.11 0.11 0.11 0.11 0.11 0.09 0.09 0.09 -0.07 0.09
Total assets 2.25 2.35 2.25 2.43 2.37 2.56 1.76 1.81 1.91 2.06 0.98 1.07 1.07 0.81 0.83 0.63 0.68 0.74 0.73 0.77 0.81 0.57 0.60 0.45 0.45 0.22 0.23 0.17
Total current liabilities + 0.29 0.29 0.25 0.18 0.16 0.16 0.11 0.11 0.09 0.14 0.09 0.08 0.05 0.06 0.07 0.06 0.06 0.06 0.05 0.05 0.04 0.05 0.04 0.04 0.04 0.04 0.04 0.03
Total non-current liabilities + 0.46 0.43 0.41 0.38 0.13 0.13 0.09 0.08 0.09 0.09 0.06 0.06 0.07 0.06 0.07 0.07 0.07 0.08 0.04 0.04 0.05 0.05 0.05 0.05 0.03 0.02 0.03 0.04
Total liabilities 0.75 0.72 0.66 0.56 0.29 0.29 0.20 0.19 0.18 0.24 0.15 0.14 0.12 0.13 0.14 0.13 0.13 0.14 0.10 0.09 0.09 0.09 0.09 0.09 0.07 0.07 0.07 0.07
Total stockholders' equity + 1.50 1.63 1.60 1.87 2.08 2.27 1.57 1.62 1.73 1.83 0.84 0.93 0.95 0.69 0.68 0.50 0.55 0.60 0.64 0.69 0.72 0.47 0.51 0.36 0.39 0.15 0.17 0.10 0.10
Common shares outstanding 198 190 189 188 188 168 167 165 165 141 109 107 95 89 85 74 74 74 74 73 70 66 65 59 29 36 36 36 36 36
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + -0.90 -0.56 -0.35 -0.22 -0.15 -0.10 -0.05 0.00 -0.03
Cash flow from investing + 0.12 -0.55 -0.34 -0.02 -0.14 -0.23 -0.10 0.00 0.00
Cash flow from financing + 0.62 0.96 1.23 0.30 0.29 0.42 0.10 0.06 0.02
Change in cash -0.16 -0.15 0.54 0.05 0.00 0.09 -0.05 0.06 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Operating cash flow + -0.35 -0.27 -0.21 -0.22 -0.19 -0.14 -0.13 -0.13 -0.16 -0.12 -0.10 -0.07 -0.06 -0.06 -0.05 -0.06 -0.06 -0.04 -0.04 -0.03 -0.04 -0.03 -0.03 -0.02 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 0.01
Cash flow from investing + 0.17 0.07 0.02 0.03 -0.02 -0.39 -0.02 0.11 -0.25 -0.38 0.08 -0.04 0.00 -0.01 -0.12 0.06 0.04 0.01 -0.03 -0.12 0.00 0.06 -0.10 -0.14 -0.06 0.01 -0.06 -0.06 0.01 0.00 0.00
Cash flow from financing + 0.24 0.37 0.00 0.26 0.00 0.87 0.08 0.01 0.00 0.84 0.00 0.06 0.32 0.05 0.25 0.00 0.00 0.01 0.00 0.00 0.28 0.00 0.17 0.00 0.25 0.00 0.01 0.09 0.00 0.00 0.06
Change in cash 0.06 0.17 -0.18 0.07 -0.21 0.34 -0.07 -0.01 -0.41 0.34 -0.02 -0.05 0.27 -0.02 0.07 0.01 -0.01 -0.02 -0.07 -0.16 0.25 0.04 0.04 -0.16 0.17 -0.01 -0.06 0.02 -0.01 -0.01 0.07
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Shares Outstanding Diluted

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Change In Inventory

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Net Income

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Cashflow From Investment

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Capital Expenditures

1Y 2Y 5Y Max
about 2 months ago

Revolution Medicines, Inc. (RVMD) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
about 2 months ago